ARTICLE | Company News
InfiMed, Praecis deal
January 8, 2001 8:00 AM UTC
InfiMed will apply its Improved Formulation Entity (IFE) technology, which uses a polyethylene glycol (PEG)-based hydrogel for sustained release delivery of protein drugs, to an undisclosed PRCS pepti...